TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 7 | 8 | 23 | 1 | -15 | -2 | 4 |
| S | %wins | 0 | 0 | 0 | 0 | 100 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/09 16:17 | 5/14/09 | CRTX | Cornerstone Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Townsend Scott B | NC | O | GC,EVP L | S.m | -292 | 6.48 | 1 | -45 | -28 | 113 | D | -70 | 77 | 135 | 77 | 64 | 37 | -11 | -5 | 7 | 8 | 23 | 1 | -15 | -2 |
9/22/05 18:18 | 9/21/05 | CRTX | Critical Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Townsend Scott B | MA | O | VP OF LE | M.d | 5 | 4.84 | 0 | 1 | New | 1 | D | 8 | -13 | -14 | 1 | -1 | 1 | 1 | 2 | 23 | 44 | 12 | -19 | -62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |